" 520.1447 
milbemycin oxime, lufenuron, and praziquantel tablets. 
(a) specifications. each tablet contains: 
(1) 2.3 milligrams (mg) milbemycin oxime, 46 mg lufenuron, and 22.8 mg praziquantel; 
(2) 5.75 mg milbemycin oxime, 115 mg lufenuron, and 57 mg praziquantel; 
(3) 11.5 mg milbemycin oxime, 230 mg lufenuron, and 114 mg praziquantel; or 
(4) 23 mg milbemycin oxime, 460 mg lufenuron, and 228 mg praziquantel. 
(b) sponsor. see no. 058198 in  510.600(c) of this chapter. 
(c) [reserved] 
(d) conditions of use (1) dogs (i) amount. 0.5 mg milbemycin oxime, 10 mg lufenuron, and 5 mg of praziquantel per kilogram of body weight, once a month. 
(ii) indications for use. for the prevention of heartworm disease caused by dirofilaria immitis; for the prevention and control of flea populations ( ctenocephalides felis ); and for the treatment and control of adult roundworm ( toxocara canis, toxascaris leonina ), adult hookworm ( ancylostoma caninum ), adult whipworm ( trichuris vulpis ), and adult tapeworm ( taenia pisiformis, echinococcus multilocularis, and e. granulosus ) infections in dogs and puppies 2 pounds of body weight or greater and 6 weeks of age and older. 
(iii) limitations. federal law restricts this drug to use by or on the order of a licensed veterinarian. 
(2) [reserved] 

